Tuesday, July 15, 2025 10:46:08 PM
The Twitter narrative tonight is hilarious.
You’ve got Dr. AI (and his two disciples) swearing that the NICE response is proof positive that the MAA has now received MHRA approval.
Their reasoning? Well, NICE confirmed the company is still fully engaged with the MHRA. Yes I know, that’s what the company has been saying for the past year, but now it’s different.
Why?
I’m glad you asked. According to the three stooges, it’s different now because NICE has confirmed NWBO is “not in a position to submit”.
So apparently NWBO has been in a position to submit for the past year and have chosen not to, but now they aren’t and it means they have gotten approved.
Am I reading that absolute bullshit right?
I’m sure none of them will admit they were wrong come two weeks when we still haven’t heard anything.
But hey, there is no accountability online. Let's just say whatever the hell we want and pretend like it never happened when we are inevitably wrong as shit.
You’ve got Dr. AI (and his two disciples) swearing that the NICE response is proof positive that the MAA has now received MHRA approval.
Their reasoning? Well, NICE confirmed the company is still fully engaged with the MHRA. Yes I know, that’s what the company has been saying for the past year, but now it’s different.
Why?
I’m glad you asked. According to the three stooges, it’s different now because NICE has confirmed NWBO is “not in a position to submit”.
So apparently NWBO has been in a position to submit for the past year and have chosen not to, but now they aren’t and it means they have gotten approved.
Am I reading that absolute bullshit right?
I’m sure none of them will admit they were wrong come two weeks when we still haven’t heard anything.
But hey, there is no accountability online. Let's just say whatever the hell we want and pretend like it never happened when we are inevitably wrong as shit.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
